STARTRIC
StarTric developes and is taken to clinical use as a transcatheter structural heart implantable device. They are developing a unique transcatheter repair implantable device to treat TR. They manage entrance to the right atrium, reducing the flow to the lungs. They offer heart failure, atrial fibrillation, and other morbidities.
STARTRIC
Social Links:
Industry:
Manufacturing Medical Medical Device
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.startric.it
Total Employee:
1+
Status:
Active
Technology used in webpage:
Google Google Cloud Wix
Similar Organizations
AUSTRAL Dx
AUSTRAL Dx is developing a new imaging technique based on airborne ultrasounds in order to map the vibrations coming from the lungs.
Corcym
Corcym is a manufacturer of surgical device focus to fight structural heart disease.
InnovHeart
InnovHeart is a developer of transcatheter mitral valve replacement systems to treat patients suffering from mitral valve disease.
Kardionet
Kardionet is a distributor of transfemoral, transapical, and transaortic heart valve products.
Neurostar
Neurostar develops and manufactures systems for Deep Brain Stimulation (DBS) surgeries and ultraprecise motorized stereotaxic.
ProVeterináře
ProVeterináře develops surgical instruments and medical devices.
Quanta
Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Stimuli Technology
Stimuli Technology develops the tensi+ overactive bladder treatment device that helps people with overactive bladder.
TSO3
TSO3 develops innovative low temperature sterile reprocessing solutions for medical devices.
Vibrosense Dynamics AB
Vibrosense Dynamics AB develops and markets medical devices for diagnosis of peripheral neuropathy.
Investors List
NLC
NLC investment in Seed Round - StarTric
Growth Engine
Growth Engine investment in Seed Round - StarTric
Official Site Inspections
http://www.startric.it
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "StarTric"
HOME | STARTRIC
StarTric can credibly combine the safety of a minimally invasive device with the efficacy of the Clover technique. Besides, its concept can make delivery easier and results more predictable, so to become truly accessible to most cardiology …See details»
StarTric - Crunchbase Company Profile & Funding
StarTric developes and is taken to clinical use as a transcatheter structural heart implantable device. They are developing a unique transcatheter repair implantable device to treat TR. …See details»
Startric Company Profile 2024: Valuation, Funding & Investors
Startric General Information Description. Developer of a structural heart technology designed to treat the regurgitation of the tricuspid valve. The company develops a minimally invasive repair …See details»
StarTric - LinkedIn
StarTric is developing an innovative structural heart technology to treat the regurgitation of the tricuspid valve. StarTric is the first and only minimally invasive repair device, conceived as a ...See details»
StarTric - Products, Competitors, Financials, Employees, …
StarTric: Transforming tricuspid regurgitation treatment StarTric develops a minimally invasive device addressing Tricuspid Regurgitation (TR). The technology can be implanted via a …See details»
2-0-3-1 - Il più grande network di premi del mondo
Sep 22, 2023 2031 è la piattaforma di premi per l’innovazione più importante in Italia e una delle più rilevanti a livello internazionale. Raccoglie il testimone del Premio Gaetano Marzotto (2010 …See details»
StarTric - Funding, Financials, Valuation & Investors - Crunchbase
Jul 8, 2024 StarTric develops a transcatheter tricuspid valve repair system to treat tricuspid heart valves. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How …See details»
Eugenio Passanante, StarTric - Transcatheter Tricuspid Valve …
Nov 7, 2024 Eugenio Passanante presents StarTric at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.StarTric’s mission is to provide a truly accessible, safe ...See details»
StarTric (company) - Nordic 9
StarTric (company). StarTric is an Italian health manufacturer developing a minimally invasive device addressing Tricuspid Regurgitation (TR) - a next-generation technology for the …See details»
Introducing StarTric: Transcatheter tricuspid heart valve repair
StarTric is poised to revolutionize the treatment of tricuspid heart valve regurgitation with the first minimally invasive, transcatheter approach that replicates the Clover surgical technique. …See details»
STAR TRIC SRL Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for STAR TRIC SRL of MILANO, MILANO. Get the latest business insights from Dun & Bradstreet.See details»
StarTric Srl: Drug pipelines, Patents, Clinical trials - Synapse
Jun 16, 2023 0 Patents (Medical) associated with StarTric Srl. Login to view more data. Pipeline. Pipeline Snapshot as of 16 Jun 2023. No pipeline posted. Login to keep update.See details»
StarTric - Tech Stack, Apps, Patents & Trademarks - Crunchbase
StarTric is actively using 3 technologies for its website, according to BuiltWith. These include Microsoft Exchange Online , Wix , and Wix DNS . Website Tech Stack by BuiltWithSee details»
Amsterdam’s NLC Health Ventures backs Milan’s StarTric - Silicon …
StarTric: Transforming tricuspid regurgitation treatment StarTric develops a minimally invasive device addressing Tricuspid Regurgitation (TR). The technology can be implanted via a …See details»
StarTric Management Team - CB Insights
Explore {StarTric's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. StarTric CEO, Founder, Key Executive …See details»
StarTric - Crunchbase
StarTric develops a transcatheter tricuspid valve repair system to treat tricuspid heart valves.See details»
Financing secured to develop “personalised” tricuspid repair system
Jul 8, 2024 StarTric has finalised a new seed financing round to advance its next-generation technology for the transcatheter repair of the tricuspid heart valve. The company has …See details»
Introducing StarTric: Transcatheter tricuspid heart valve repair
StarTric is poised to revolutionize the treatment of tricuspid heart valve regurgitation with the first minimally invasive, transcatheter approach that replicates the Clover surgical technique. …See details»
A Novel Transcatheter Technique to Repair the Tricuspid Valve …
Oct 29, 2024 TCT 500: Long-term Outcomes and Predictor of Target Lesion Revascularization the Patients After Treated With Paclitaxel Coated Balloon for Drug-Eluted Stent Restenosis …See details»
StarIC, Toronto, CA | Company Information
Oct 18, 2024 In Toronto, Infobel has listed 1 registered companies. These companies have an estimated turnover of $ 867.13 millions and employ a number of employees estimated at …See details»